Olaplex Holdings Inc header image

Olaplex Holdings Inc

OLPX

Equity

ISIN US6793691089 / Valor 113471584

NASDAQ (2024-09-18)
USD 2.62+5.65%

Olaplex Holdings Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Olaplex Holdings Inc is a science-enabled beauty company focused on improving the hair health of consumers through innovative technology. The company disrupted the professional hair care industry in 2014 by introducing bond building products that protect, strengthen, and rebuild broken bonds in the hair. With patent-protected ingredients that work on a molecular level to repair damage, Olaplex's award-winning products are distributed globally through various channels, including professional salons, specialty retailers, and direct-to-consumer platforms.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Net Sales Performance

Olaplex Holdings Inc. reported a 4.8% decrease in net sales for the second quarter of 2024, totaling $103.9 million compared to the same period in 2023. The decline was driven by a mixed performance across different sales channels, with Specialty Retail increasing by 22.4% to $36.4 million, while Professional and Direct-To-Consumer channels saw decreases of 18.4% and 11.5%, respectively.

Geographical Sales Insights

For the second quarter of 2024, Olaplex Holdings Inc. experienced a 7.3% increase in net sales within the United States. However, this growth was offset by a 15.1% decrease in international sales. This geographical disparity highlights the company's stronger performance in its domestic market compared to its international operations.

Net Income and Earnings Per Share

Olaplex Holdings Inc. saw a 6.1% decrease in net income for the second quarter of 2024 compared to the same period in 2023. Despite this, the company's diluted earnings per share (EPS) remained consistent at $0.01 for both quarters. Adjusted net income also decreased by 11.6%, with adjusted diluted EPS holding steady at $0.03.

Gross Profit and Margins

In the second quarter of 2024, Olaplex Holdings Inc. reported a gross profit of $72.4 million, down from $77.5 million in the same quarter of the previous year. The gross profit margin slightly decreased to 69.7% from 70.9%. Adjusted gross profit was $74.7 million, with an adjusted gross profit margin of 71.9%, reflecting a minor decline from the previous year's 72.7%.

Fiscal Year 2024 Guidance

Olaplex Holdings Inc. reiterated its fiscal year 2024 guidance, projecting net sales between $435 million and $463 million. The company also expects adjusted net income to range from $87 million to $100 million and adjusted EBITDA between $143 million and $159 million. This guidance reflects management's confidence in the company's long-term growth potential and strategic direction.

Summarized from source with an LLMView Source

Key figures

25.4%1Y
%3Y
%5Y

Performance

81.6%1Y
86.0%3Y
86.0%5Y

Volatility

Market cap

1342 M

Market cap (USD)

Daily traded volume (Shares)

1,415,018

Daily traded volume (Shares)

1 day high/low

2.755 / 2.49

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Icon PLC
Icon PLC Icon PLC Valor: 1017575
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.39%USD 302.45
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.86%USD 30.71
Coty Inc
Coty Inc Coty Inc Valor: 1645885
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 9.26
Faes Farma SA
Faes Farma SA Faes Farma SA Valor: 2837976
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.36%EUR 3.72
Viatris Inc
Viatris Inc Viatris Inc Valor: 58198423
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.68%USD 11.90
Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.53%USD 72.87
Ensign Group Inc
Ensign Group Inc Ensign Group Inc Valor: 3109721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.68%USD 151.00
Viking Therapeutics Inc
Viking Therapeutics Inc Viking Therapeutics Inc Valor: 24839858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.40%USD 64.45
HealthEquity Inc
HealthEquity Inc HealthEquity Inc Valor: 24679014
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%USD 77.54
CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%USD 315.19